bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors - Business Wire
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors Business Wire
393 материалов по теме, собраны автоматически из проверенных источников
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors Business Wire
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study Y100 WNCY
AstraZeneca-Hutchmed drug combination shows promise in advanced lung cancer study srnnews.com
Baptist Cancer Center studying personalized mRNA vaccines to fight lung cancer FOX13 Memphis
HUTCHMED (HCM) lung cancer combo tops China Phase III trial Stock Titan
IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer PR Newswire
Thymus Radiation Exposure Tied to Worse Lung Cancer Outcomes Medscape
Гинцбург: меланома и рак легких могут быть побеждены за 3-6 лет Дзен
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China Yahoo Finance
Previously, the primary endpoint results of the NRG-LU005 (NCT03811002) study assessing the addition of the immunotherapy drug atezolizumab (Tecentriq) to standard-of-care concurrent chemoradiation for limited-stage small-cell lung cancer were reported at the American Society for Radiation Oncology 2024 Annual…
Could Lung Cancer Develop Differently in Younger Adults? – Oncogene Cancer Research Oncodaily
Could Lung Cancer Develop Differently in Younger Adults? – Oncogene Cancer Research Oncodaily
Exercise May Reverse Obesity-Induced Immune Suppression in Lung Cancer Oncology Nursing News
Stage 4 lung cancer survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson UT MD Anderson
Protecting the thymus may improve lung cancer treatment outcomes News-Medical